Oxford Brain Diagnostics awarded £1.4m to test technology in NHS
A spinout from the University of Oxford, Oxford Brain Diagnostics, run by Dr Steven Change (see photo above), is a software company focused on developing diagnostics based on changes in the brain at cellular level. The project will assess Cortical Disarray Measurement, or CDM, as a tool to diagnose mild cognitive impairment due to Alzheimer’s disease. The grant highlights the critical need for continued investment in the UK for dementia and to explore breakthrough technologies that can support improved diagnostics. The CDM software device was awarded Breakthrough Device designation by the FDA in August 2020.
Alzeheimer’s remains a complex condition so examining MRI scan data from the NHS at the earliest stages of the disease provides a valuable opportunity to estimate patient progress, assess the future economic impact patients will have in long-term care, provide valuable time for families to adjust, and get access to new drug treatments
The multi-centre project is led by Oxford Brain Diagnostics but includes the University of Oxford Health Economics Research Centre, University Hospital Southampton NHS Foundation Trust, NIHR community Healthcare MedTech and IVD Cooperative Cardif & the Vale University Health Board, Cardiff, Southampton, South Wales universities and Bournemouth University Institute of Medical Imaging and Visualisation.
Createc’s ground-breaking robot
Createc has been developing smart radiation detection and 3D gamma radiation mapping technology over the last few years. Their ‘N-Visage®’ sensor has been deployed worldwide, including at the Fukushima Daichi nuclear power plant in Japan after the devastating earthquake and tsunami in 2011.
Astrid Education strengthens leadership team with key hire from King
With a background from King and the Candy Crush franchise, Astrid’s new hire John Almbecker brings with him a broad experience of product development and building world-class digital consumer experiences.
Optellum goes global with breakthrough
One of our Oxford Centre for Innovation-based companies, Optellum launches the world’s first AI decision support for early lung cancer detection.